Jack Nathan Medical Corp.
JNH.V
TSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 690.31% | 177.28% | 18.51% | -106.37% | -108.24% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 690.31% | 177.28% | 18.51% | -106.37% | -108.24% |
| Cost of Revenue | 447.43% | 7.52% | -19.70% | -100.62% | -94.81% |
| Gross Profit | 550.86% | 274.85% | 29.70% | -108.15% | -112.06% |
| SG&A Expenses | 1,092.41% | 113.29% | 23.46% | -91.55% | -95.73% |
| Depreciation & Amortization | 189.49% | 214.96% | -13.27% | -111.74% | -119.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,370.55% | 92.91% | 14.82% | -94.21% | -96.91% |
| Operating Income | 23.28% | 16.99% | -3.12% | 49.47% | 55.71% |
| Income Before Tax | -17.54% | -3.00% | -10.22% | 86.46% | 80.01% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -200.00% | -69.66% | -76.54% | 96.65% | 92.01% |
| Earnings from Discontinued Operations | 4,480.71% | 25,430.50% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 229.00% | 203.66% | 206.38% | 26.05% | 8.45% |
| EBIT | 23.28% | 16.99% | -3.12% | 49.47% | 55.71% |
| EBITDA | -4.00% | 3.30% | -11.97% | 63.55% | 68.21% |
| EPS Basic | 227.48% | 202.12% | 204.50% | 26.76% | 9.03% |
| Normalized Basic EPS | 19.39% | 2.65% | -5.93% | 61.59% | 63.70% |
| EPS Diluted | 222.12% | 195.45% | 199.16% | 26.75% | 9.88% |
| Normalized Diluted EPS | 30.69% | 13.04% | 4.17% | 61.15% | 62.31% |
| Average Basic Shares Outstanding | 2.32% | 1.63% | 1.06% | 0.66% | 0.70% |
| Average Diluted Shares Outstanding | 2.95% | 3.13% | 2.57% | 2.09% | 1.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |